CORONAVIRUS DISEASE (COVID-19) ASSOCIATED MUCORMYCOSIS
*Dr. Swati Srivastava, Dr. Raunak Manjeet, Dr. Mohan Rawat, Dr. Ankit, Dr. Anwar Ashraf and Dr. Pratistha Agarwal
Severe coronavirus disease (COVID-19) is currently managed with systemic glucocorticoids. Opportunistic fungal infections are of concern in such patients. Post-Covid mucormycosis has emerged massively in the second wave in India. A Covid survivor who has already suffered the brunt of a disease which affects almost all the systems of human body has to also face the deadly fungal disease. Most common type of mucormycosis being rhino-maxillary disease patients might report primarily to general dental practitioner for oral cavity related complains. So, this article gives a detail of Sign, Symptoms & treatment planning of the disease.
[Full Text Article]